Visceral obesity augments prescription use: An analysis of the cross-sectional study of NHANES 2011-2018.

Visceral obesity augments prescription use: An analysis of the cross-sectional study of NHANES 2011-2018.

<h4>Background</h4>Visceral obesity (VATob) increases the risk for many diseases. Central obesity has been associated with an augmented prescription use; however, there is a paucity of research focused on VATob. Here, the aim was to evaluate the association between VATob and prescription...

Full description

Saved in:
Bibliographic Details
Main Authors: Maximino Acevedo-Fernández, Renata Ochoa Precoma, Leonardo M Porchia, Victor M Posadas, Enrique Torres-Rasgado, M Elba Gonzalez-Mejia, Esther López-Bayghen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0318413
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items